期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
诊癌明日之星 光环褪去
1
作者 罗丹 《国外科技动态》 2004年第6期14-15,共2页
很少有单独的某项研究可以促使美国国会通过决议,竭力要求为一种新的诊断检测方法进入临床应用提供持续资助。但这一幕恰巧在2002年上演了。但也是从那个时候开始,对这一被誉为癌症诊断学明日之星的蛋白组检测法有效性的质疑者开始与... 很少有单独的某项研究可以促使美国国会通过决议,竭力要求为一种新的诊断检测方法进入临床应用提供持续资助。但这一幕恰巧在2002年上演了。但也是从那个时候开始,对这一被誉为癌症诊断学明日之星的蛋白组检测法有效性的质疑者开始与日俱增。 展开更多
关键词 诊断检测方法 癌症诊断 蛋白组检测法 有效性 蛋白质图谱
下载PDF
Establishment of an ELISA to Detect Kaposi's Sarcoma-associated Herpesvirus Using Recombinant ORF73 被引量:8
2
作者 Xin-xing OUYANG Bi-shi FU +3 位作者 Bao-lin LI Yan ZENG Fan-hong XU Lin-ding WANG 《Virologica Sinica》 SCIE CAS CSCD 2010年第3期168-176,共9页
Kaposi's sarcoma-associated herpesvirus (KSHV) is causally related to Kaposi's sarcoma (KS), primary effusion lymphoma (PEL) and a proportion of cases of multicentric Castleman's disease (MCD). The ORF73 p... Kaposi's sarcoma-associated herpesvirus (KSHV) is causally related to Kaposi's sarcoma (KS), primary effusion lymphoma (PEL) and a proportion of cases of multicentric Castleman's disease (MCD). The ORF73 protein was cloned into pQE80L-orf73 and expressed in E.coli and purified. The expressed recombinant ORF73 was identified by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). A protein of about 27 kDa was expressed as expected. Western Blotting showed that the purified recombinant ORF73 reacted with KSHV positive serum. The immunogenicity of the recombinant ORF73 was further analysed by ELISA and the optimal conditions were determined. The ORF73 ELISA was used to compare the KSHV seroprevalence between Hubei and Xinjiang Han people. The Han people in Xinjiang have significantly higher KSHV seroprevalence than their counterparts in Hubei (6.7% vs 2.9%, P = 0.005). 展开更多
关键词 Kaposi's sarcoma-associated herpesvirus (KSHV) ORF73 ELISA HUBEI Xinjiang SEROPREVALENCE
下载PDF
Preparation and Characterization of Monoclonal Antibodies against VP1 Protein of Foot-and-mouth Disease Virus O/China99
3
作者 Shuai SONG Tong LIN +4 位作者 Jun-jun SHAO Shan-dian GAO Guo-zheng CONG Jun-zheng DU Hui-yun CHANG 《Virologica Sinica》 SCIE CAS CSCD 2009年第6期566-572,共7页
Monoclonal antibodies (McAbs) 1A9 and 9F12 against Foot-and-mouth disease virus (FMDV) serotype O were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with O/China99. Both McAbs reacted... Monoclonal antibodies (McAbs) 1A9 and 9F12 against Foot-and-mouth disease virus (FMDV) serotype O were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with O/China99. Both McAbs reacted with O/China99 but not with Asia 1, as determined by immunohistochemistry assay. The microneutralization titer of the McAbs 1A9 and 9F12 were 640 and 1 280, respectively. Both McAbs contain kappa light chains, but the McAbs 1A9 and 9F12 were IgG1 and IgM, respectively. In order to define the McAbs binding epitopes, the reactivity of these McAbs against VP1, P20 and P14 were examined using indirect ELISA, the result showed that both McAbs reacted with VP1 and P20. McAbs may be used for further studies of vaccine, diagnostic methods, prophylaxis, etiological and immunological researches on FMDV. 展开更多
关键词 Foot-and-mouth disease virus (FMDV) Monoclonal antibody Neutralizing activity VP1 protein
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部